Donald Smith, MD, MPH
Smith D. Review: Pioglitazone does not reduce risk for mortality or cardiovascular events in type 2 diabetes. ACP J Club. 2007;146:40. doi: 10.7326/ACPJC-2007-146-2-040
Download citation file:
Published: ACP J Club 2007;146(2):40.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only